Evidence map›Paper›PMID 42164275›Full record

ArticleFrontiers in artificial intelligence2026

An automated framework to classify skin lesions using Multi-Head Self Attention Layer-based Vision Transformers.

Sahil Faizal, Charu Anant Rajput, Manas Ranjan Prusty

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sahil FaizalSchool of Computer Science and Engineering, Vellore Institute of Technology, Chennai, India.
Charu Anant RajputSchool of Computer Science and Engineering, Vellore Institute of Technology, Chennai, India.
Manas Ranjan PrustyCentre for Cyber Physical Systems, Vellore Institute of Technology, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin lesions are one of the most prevalent form of diseases existing among us. Early detection and classification of potentially malignant skin lesions can give us a lead in the fight against skin cancer. There are many lesion classification divisions on medical grounds; however, an automated system that detects and classifies a majority of these classes is not prevalent. In view of this scenario, our proposed study aims to classify the input skin lesion images into nine classes, namely, squamous cell carcinoma (SCC), Basal cell carcinoma (BCC), melanocytic nevi (NV), actinic keratoses and intraepithelial carcinoma (AKIEC), melanoma (MEL), seborrheic keratosis (SEK), dermatofibroma (DF), benign keratosis like lesions (BKL), and vascular lesions (VASC). The proposed methodology uses contrast stretching as an image enhancement technique to facilitate efficient Region of Interest (ROI) segmentation. The novelty of the proposed study lies in the first-hand implementation of Vision Transformer (ViT) for feature extraction in the domain of skin lesion detection. Finally, a light-weight multi-layer perceptron (MLP) composed of fully connected layers is used for multinomial classification. Combining the aforementioned techniques, the proposed method achieves training accuracy of 98% and testing accuracy of about 93.22%. The impressive performance across nine distinct categories represents a significant milestone. This success demonstrates the model's scalability, suggesting it can be effectively extended to a broader array of diagnostic classes in future research.

Indexed as

contrast stretchingMulti-Head Self Attention Layermulti-layer perceptronskin lesion detectionVision Transformers

Identifiers

PMID42164275
PMCPMC13183645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.